MUSE awarded a Marie Curie ITN grant: VPH CaSE
11 September 2014
MUSE has been awarded a new grant, a Marie Curie ITN "VPH CaSE" (VPH-Cardiovascular Simulation and Experimentation for Personalised Medical Devices).
The consortium combines the expertise of nine core Beneficiaries (5 academic, 4 industrial) and 10 Partners (5 clinical, 4 industrial, 1 academic), which are all centres of excellence in cardiovascular engineering. It has strategic partnerships with ANSYS, Leeds Test Objects, Therenva and Lifetec.
VPH CaSE is focused on state-of-the-art developments in personalised cardiovascular support, underpinned by simulation and experimentation, building on the foundations of the Virtual Physiological Human (VPH) Initiative.
The research will focus on three research clusters
(i) Cardiac tissue function and cardiac support
(ii) Cardiovascular haemodynamics - pathology and intervention
(iii) Image-based diagnosis and imaging quality assurance.
The work will be directed by the needs of industrial and clinical beneficiaries and partners. The inclusion of a technology translation SME within the consortium is designed to promote the delivery of novel, tangible research outputs, providing benefits to a breadth of European sectors (eg. biomedical, clinical, VPH).